SCHEMBL22274247

SCHEMBL22274247

CCCCCCCCCCC(O)CCCCCCC/C=C\CC(CCCCCC)OC(=O)CCCCC

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.61
FFAR4 Q5NUL3 1/20 0.61
PRKCA P17252 2/20 0.57
PRKCE Q02156 1/20 0.57
PRKCQ Q04759 1/20 0.57
PRKCD Q05655 1/20 0.57
FAAH O00519 3/20 0.54
MAPT P10636 2/20 0.54
ALDH1A1 P00352 1/20 0.54
HPGD P15428 1/20 0.54
CNR1 P21554 1/20 0.54
CNR2 P34972 1/20 0.54
DGKA P23743 1/20 0.53
SLC6A5 Q9Y345 1/20 0.53
LPAR1 Q92633 1/20 0.52
DAGLA Q9Y4D2 2/20 0.50
S1PR1 P21453 1/20 0.50
MAPK1 P28482 1/20 0.50
SELP P16109 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17744101 1.00 FFAR1 (0.61) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL17744104 1.00 FFAR1 (0.61) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL17744098 1.00 FFAR1 (0.61) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL22550050 0.96 FFAR1 (0.67) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL3874930 0.95 FFAR1 (0.70) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL27402994 0.95 FFAR1 (0.56) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL22274216 0.95 FFAR4 (0.58) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL17744005 0.95 FFAR4 (0.58) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL17744007 0.95 FFAR4 (0.58) FFAR1FFAR4PRKCAPRKCEPRKCQ
SCHEMBL17744006 0.95 FFAR4 (0.58) FFAR1FFAR4PRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10731159-B2 Cationic lipid DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10731159-B2 Cationic lipid CETP, NPC1L1, LIPA FFAR1 161/4885FFAR4 175/4885PRKCA 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.